CROI 2017 Program and Information

Program and Agenda

694 RANDOMIZED TRIAL OF BEHAVIORALWEIGHT LOSS FOR HIV-INFECTED PATIENTS Katie Becofsky 1 , Edward J. Wing 2 , Jeanne McCaffery 3 , Matthew Boudreau 3 , Rena R. Wing 3 1 Univ of Massachusetts Amherst, Amherst, MA, USA, 2 Brown Univ, Providence, RI, USA, 3 The Miriam Hosp, Providence, RI, USA 695 PREDICTORS OF SEVEREWEIGHT/BODYMASS INDEX GAIN FOLLOWING ANTIRETROVIRAL INITIATION Priya Bhagwat 1 , Igho Ofotokun 2 , Grace A. McComsey 3 , Todd Brown 4 , Carlee Moser 5 , Catherine A. Sugar 1 , Judith S. Currier 1 1 Univ of California Los Angeles, Los Angeles, CA, USA, 2 Emory Univ, Atlanta, GA, USA, 3 Case Western Reserve Univ, Cleveland, OH, USA, 4 The Johns Hopkins Univ, Baltimore, MD, USA, 5 Harvard Univ, Boston, MA, USA 696 RALTEGRAVIR SWITCH AND BIOMARKERS OF LIVER STEATOSIS ANDMETABOLIC SYNDROME INWOMEN David Reynoso 1 , Anoma Somasunderam 1 , Maitreyee Nigalye 1 , Judith S. Currier 2 , Netanya S. Utay 1 , Jordan E. Lake 3 1 Univ of Texas Med Branch at Galveston, Galveston, TX, USA, 2 Univ of California Los Angeles, Los Angeles, CA, USA, 3 Univ Texas Houston, Houston, TX, USA 697 CHANGES IN LIVER STEATOSIS AFTER SWITCHING EFAVIRENZ TO RALTEGRAVIR: THE STERAL STUDY Juan Macías 1 , Dolores Merino 2 , Francisco Téllez 3 , Federico Pulido 4 , Juan González-Garcia 5 , Manuel Márquez 6 , Antonio Rivero 7 , María Mancebo 1 , Juan A. Pineda 1 , for the RIS-HEP09 1 Hosp Univ de Valme, Sevilla, Spain, 2 Complejo Hospario Univ de Huelva, Huelva, Spain, 3 Hosp Univ de Puerto Real, Cádiz, Spain, 4 Hosp 12 de Octubre, Madrid, Spain, 5 Hosp Univ La Paz, Madrid, Spain, 6 Hosp Virgen de la Victoria, Málaga, Spain, 7 Hosp Univ Reina Sofia, Cordoba, Spain Themed Discussion Leader Aaron Siegler, Emory Univ, Atlanta, GA, USA 961 FEASIBILITY OF A PHARMACIST-RUNHIV PREP CLINIC IN A COMMUNITY PHARMACY SETTING Elyse Tung 1 , Annalisa Thomas 1 , Allyson Eichner 1 , Peter Shalit 2 1 Kelley-Ross Pharm, Seattle, WA, USA, 2 Univ of Washington, Seattle, WA, USA 962 ASSESSING THE EFFICACY AND FEASIBILITY OF A RETAIL PHARMACY-BASED HIV TESTING PROGRAM Bryan C. Collins , Heather W. Bronson, Elaine G. Martin Virginia Dept of Hlth, Richmond, VA, USA 963 MIDWEST PHARMACISTS’KNOWLEDGE OF &WILLINGNESS TO PROVIDE PREEXPOSURE PROPHYLAXIS Jordan Broekhuis , Kimberly K. Scarsi, Harlan Sayles, Donald Klepser, Joshua Havens, Susan Swindells, Sara H. Bares Univ of Nebraska, Omaha, NE, USA 964 TEXTMESSAGING IS ASSOCIATEDWITH IMPROVED RETENTION IN A CLINIC-BASED PREP PROGRAM Christine M. Khosropour 1 , Richard T. Lester 2 , Matthew R. Golden 1 , Julia C. Dombrowski 1 1 Univ of Washington, Seattle, WA, USA, 2 Univ of British Columbia, Vancouver, British Columbia, Canada Themed Discussion TD-5: PREPWITHOUT BORDERS: NEW DELIVERY OPTIONS Room 6 E 1:30 PM - 2:30 PM

Oral Sessions • Tuesday

CROI 2017 41